{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Gliclazide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Gliclazide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Gliclazide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "gliclazide",
    "trial_2_text": "Gliclazide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Gliclazide Supplement: 60 participants will take Gliclazide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Gliclazide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Gliclazide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.08594698458909988,
      "78": 0.060159750282764435,
      "177": 0.049434736371040344,
      "64": 0.04835456609725952,
      "173": 0.047139834612607956,
      "28": 0.04127053543925285,
      "9": 0.04119831696152687,
      "46": 0.041153501719236374,
      "20": 0.04010159894824028,
      "67": 0.03929976001381874,
      "37": 0.03927694633603096,
      "17": 0.03861471265554428,
      "21": 0.03414806351065636,
      "123": 0.03384780138731003,
      "189": 0.03372973948717117,
      "151": 0.02891606278717518,
      "77": 0.02702147141098976,
      "228": 0.026631131768226624,
      "29": 0.026541905477643013,
      "132": 0.02639332227408886,
      "49": 0.02603214979171753,
      "243": 0.025459911674261093,
      "188": 0.023386741057038307,
      "76": 0.023071689531207085,
      "14": 0.022685518488287926,
      "85": 0.022501826286315918,
      "68": 0.02229068987071514,
      "79": 0.021694287657737732,
      "104": 0.02134411595761776,
      "86": 0.021246902644634247,
      "96": 0.020861996337771416,
      "101": 0.020373359322547913,
      "126": 0.020200230181217194,
      "114": 0.01918914169073105,
      "200": 0.019075004383921623,
      "350": 0.01840200088918209,
      "193": 0.018397869542241096,
      "122": 0.018315618857741356,
      "61": 0.0182659849524498,
      "138": 0.017950676381587982,
      "180": 0.01786731369793415,
      "131": 0.01785030961036682,
      "121": 0.01780254766345024,
      "92": 0.01754038594663143,
      "147": 0.016683248803019524,
      "2": 0.016559217125177383,
      "30": 0.015922410413622856,
      "234": 0.015672311186790466,
      "142": 0.015406104736030102,
      "36": 0.014770098961889744,
      "179": 0.014386783353984356,
      "82": 0.014194482006132603,
      "466": 0.014189470559358597,
      "356": 0.014070253819227219,
      "139": 0.013890238478779793,
      "118": 0.01386514026671648,
      "199": 0.013767749071121216,
      "269": 0.013611940667033195,
      "441": 0.0135481096804142,
      "18": 0.013483432121574879,
      "242": 0.01341029442846775,
      "69": 0.013326507993042469,
      "361": 0.01332028303295374,
      "130": 0.013041721656918526,
      "5": 0.013021734543144703,
      "31": 0.012911931611597538,
      "72": 0.012799475342035294,
      "38": 0.012657469138503075,
      "33": 0.0125215332955122,
      "136": 0.012023556977510452,
      "239": 0.012009738013148308,
      "27": 0.01193684060126543,
      "194": 0.01193371880799532,
      "396": 0.011865716427564621,
      "98": 0.011834118515253067,
      "4": 0.011768776923418045,
      "204": 0.011707925237715244,
      "116": 0.011400080285966396,
      "262": 0.01135963574051857,
      "221": 0.011283615604043007,
      "456": 0.011274830438196659,
      "102": 0.011174584738910198,
      "191": 0.01096637174487114,
      "371": 0.01085609570145607,
      "154": 0.010830605402588844,
      "11": 0.010744737461209297,
      "310": 0.010600373148918152,
      "261": 0.010333135724067688,
      "276": 0.010189746506512165,
      "75": 0.010167915374040604,
      "249": 0.010062675923109055,
      "186": 0.009880849160254002,
      "288": 0.009823647327721119,
      "195": 0.009754179045557976,
      "133": 0.00955207459628582,
      "300": 0.00954908411949873,
      "253": 0.009462256915867329,
      "178": 0.009424486197531223,
      "83": 0.009371397085487843,
      "19": 0.009365069679915905
    },
    "trial_2_ae": {
      "87": 0.08594698458909988,
      "78": 0.060159750282764435,
      "177": 0.049434736371040344,
      "64": 0.04835456609725952,
      "173": 0.047139834612607956,
      "28": 0.04127053543925285,
      "9": 0.04119831696152687,
      "46": 0.041153501719236374,
      "20": 0.04010159894824028,
      "67": 0.03929976001381874,
      "37": 0.03927694633603096,
      "17": 0.03861471265554428,
      "21": 0.03414806351065636,
      "123": 0.03384780138731003,
      "189": 0.03372973948717117,
      "151": 0.02891606278717518,
      "77": 0.02702147141098976,
      "228": 0.026631131768226624,
      "29": 0.026541905477643013,
      "132": 0.02639332227408886,
      "49": 0.02603214979171753,
      "243": 0.025459911674261093,
      "188": 0.023386741057038307,
      "76": 0.023071689531207085,
      "14": 0.022685518488287926,
      "85": 0.022501826286315918,
      "68": 0.02229068987071514,
      "79": 0.021694287657737732,
      "104": 0.02134411595761776,
      "86": 0.021246902644634247,
      "96": 0.020861996337771416,
      "101": 0.020373359322547913,
      "126": 0.020200230181217194,
      "114": 0.01918914169073105,
      "200": 0.019075004383921623,
      "350": 0.01840200088918209,
      "193": 0.018397869542241096,
      "122": 0.018315618857741356,
      "61": 0.0182659849524498,
      "138": 0.017950676381587982,
      "180": 0.01786731369793415,
      "131": 0.01785030961036682,
      "121": 0.01780254766345024,
      "92": 0.01754038594663143,
      "147": 0.016683248803019524,
      "2": 0.016559217125177383,
      "30": 0.015922410413622856,
      "234": 0.015672311186790466,
      "142": 0.015406104736030102,
      "36": 0.014770098961889744,
      "179": 0.014386783353984356,
      "82": 0.014194482006132603,
      "466": 0.014189470559358597,
      "356": 0.014070253819227219,
      "139": 0.013890238478779793,
      "118": 0.01386514026671648,
      "199": 0.013767749071121216,
      "269": 0.013611940667033195,
      "441": 0.0135481096804142,
      "18": 0.013483432121574879,
      "242": 0.01341029442846775,
      "69": 0.013326507993042469,
      "361": 0.01332028303295374,
      "130": 0.013041721656918526,
      "5": 0.013021734543144703,
      "31": 0.012911931611597538,
      "72": 0.012799475342035294,
      "38": 0.012657469138503075,
      "33": 0.0125215332955122,
      "136": 0.012023556977510452,
      "239": 0.012009738013148308,
      "27": 0.01193684060126543,
      "194": 0.01193371880799532,
      "396": 0.011865716427564621,
      "98": 0.011834118515253067,
      "4": 0.011768776923418045,
      "204": 0.011707925237715244,
      "116": 0.011400080285966396,
      "262": 0.01135963574051857,
      "221": 0.011283615604043007,
      "456": 0.011274830438196659,
      "102": 0.011174584738910198,
      "191": 0.01096637174487114,
      "371": 0.01085609570145607,
      "154": 0.010830605402588844,
      "11": 0.010744737461209297,
      "310": 0.010600373148918152,
      "261": 0.010333135724067688,
      "276": 0.010189746506512165,
      "75": 0.010167915374040604,
      "249": 0.010062675923109055,
      "186": 0.009880849160254002,
      "288": 0.009823647327721119,
      "195": 0.009754179045557976,
      "133": 0.00955207459628582,
      "300": 0.00954908411949873,
      "253": 0.009462256915867329,
      "178": 0.009424486197531223,
      "83": 0.009371397085487843,
      "19": 0.009365069679915905
    }
  },
  "safety": {
    "trial_1_safety": 0.21061937510967255,
    "trial_2_safety": 0.21061937510967255
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4827801287174225
  }
}